Alpha-interferon therapy and cutaneous vascular lesions.
Dreno
B
B
Huart
A
A
Billaud
E
E
Litoux
P
P
Godefroy
W Y
WY
D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D007375:Interleukin-1 / Q000096:biosynthesis; D007376:Interleukin-2 / Q000096:biosynthesis; D008875:Middle Aged; D011994:Recombinant Proteins; D012871:Skin Diseases / Q000209:etiology* / Q000378:metabolism; D013684:Telangiectasis / Q000209:etiology* / Q000378:metabolism
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007375:Interleukin-1; D007376:Interleukin-2; D011994:Recombinant Proteins